These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos. Nikitovic D; Holmgren A; Spyrou G Biochem Biophys Res Commun; 1998 Jan; 242(1):109-12. PubMed ID: 9439619 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos. Handel ML; Watts CK; deFazio A; Day RO; Sutherland RL Proc Natl Acad Sci U S A; 1995 May; 92(10):4497-501. PubMed ID: 7753832 [TBL] [Abstract][Full Text] [Related]
4. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Echlin DR; Tae HJ; Mitin N; Taparowsky EJ Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209 [TBL] [Abstract][Full Text] [Related]
5. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells. Zhao B; Yu W; Qian M; Simmons-Menchaca M; Brown P; Birrer MJ; Sanders BG; Kline K Mol Carcinog; 1997 Jul; 19(3):180-90. PubMed ID: 9254885 [TBL] [Abstract][Full Text] [Related]
6. Expression and distribution of AP-1 transcription factors in the porcine ovary. Rusovici R; LaVoie HA Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371 [TBL] [Abstract][Full Text] [Related]
7. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites. Ramirez-Carrozzi VR; Kerppola TK J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600 [TBL] [Abstract][Full Text] [Related]
8. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers. Suzukawa K; Colburn NH Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401 [TBL] [Abstract][Full Text] [Related]
10. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells. Agadir A; Shealy YF; Hill DL; Zhang X Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011 [TBL] [Abstract][Full Text] [Related]
11. Bovine dialyzable leukocyte extract modulates AP-1 DNA-binding activity and nuclear transcription factor expression in MCF-7 breast cancer cells. Mendoza-Gamboa E; Franco-Molina MA; Zapata-Benavides P; Castillo-Tello P; Vera-García ME; Tamez-Guerra RS; Rodríguez-Padilla C Cytotherapy; 2008; 10(2):212-9. PubMed ID: 18368600 [TBL] [Abstract][Full Text] [Related]
12. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737 [TBL] [Abstract][Full Text] [Related]
13. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression. Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529 [TBL] [Abstract][Full Text] [Related]
15. Impaired AP-1 dimers and NFAT complex formation in immature thymocytes during in vivo glucocorticoid-induced apoptosis. Wisniewska M; Pyrzynska B; Kaminska B Cell Biol Int; 2004; 28(11):773-80. PubMed ID: 15563399 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es). Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation. Melino G; Bernassola F; Catani MV; Rossi A; Corazzari M; Sabatini S; Vilbois F; Green DR Cancer Res; 2000 May; 60(9):2377-83. PubMed ID: 10811113 [TBL] [Abstract][Full Text] [Related]
18. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types. Barrett TJ; Vedeckis WV Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052 [TBL] [Abstract][Full Text] [Related]
19. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells]. Chuĭkin IA; Lianguzova MS; Pospelov VA Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838 [TBL] [Abstract][Full Text] [Related]
20. Modulation of transcription factor AP-1 activity in murine EL-4 thymoma cells by vomitoxin (deoxynivalenol). Li S; Ouyang Y; Yang GH; Pestka JJ Toxicol Appl Pharmacol; 2000 Feb; 163(1):17-25. PubMed ID: 10662601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]